Miromatrix Medical Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
1
Ending by 2030
Aug 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Sep 22, 2027The maintenance fee for Methods of decellularizing bone (US 9,290,738) comes due Sep 22, 2027. Unpaid by Mar 22, 2028, it lapses early.
Recent changes
- 2 terms have ended since Aug 23, 2026
- Aug 28 US 10,441,609 Decellularization and Recellularization of Solid Organs · term ended
- Aug 28 US 10,220,056 Decellularization and Recellularization of Solid Organs · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,470,520 | Decellularization and Recellularization of Organs and Tissues In force · High confidence | In force | High confidence | |
| US 10,233,420 | Methods of Recellularizing a Tissue or Organ for Improved Transplantability In force · High confidence | In force | High confidence | |
| US 11,414,644 | Methods of Recellularizing a Tissue or Organ for Improved Transplantability In force · High confidence | In force | High confidence | |
| US 12,084,677 | Methods of Recellularizing a Tissue or Organ for Improved Transplantability In force · Low confidence | In force | Low confidence | |
| US 12,522,802 | Methods of Recellularizing a Tissue or Organ for Improved Transplantability In force · Low confidence | In force | Low confidence | |
| US 9,290,738 | Methods of decellularizing bone In force · USPTO record | In force | USPTO record | |
| US 10,213,525 | Use of Perfusion Decellularized Liver for Islet Cell Recellularization In force · High confidence | In force | High confidence | |
| US 11,452,797 | Use of Perfusion Decellularized Liver for Islet Cell Recellularization In force · High confidence | In force | High confidence | |
| US 9,974,814 | Gas filled decellularized matrix In force · USPTO record | In force | USPTO record | |
| US 12,076,461 | Use of Resected Liver Serum for Whole Liver-Engineering In force · High confidence | In force | High confidence |
Also on record, not counted in the 13: 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
12 pending · 3 abandoned · 3 no status recorded